University of Patras
Ασφάλεια και αποτελεσματικότητα της Φεσοτεροδίνης σε ασθενείς με νευρογενή υπερδραστήριο εξωστήρα εξαιτίας Κάκωσης Νωτιαίου Μυελού (ΚΝΜ) ή Σκλήρυνση κατά Πλάκας (ΣκΠ)
Abstract
dc:descriptionAntimuscarinic drugs are the first‐line choice in the treatment of patients with neurogenic Detrusor Overactivity. Fesoterodine fumarate is the newest antimuscarinic drug. Limited data are published about the use of fesoterodine fumarate in patients suffering from neurogenic lower urinary tract dysfunction. Our study aims to determine the efficacy of fesoterodine fumarate on patients with neurogenic Detrusor Overactivity due to Spinal Cord Injury or Multiple Sclerosis.This is an open‐label prospective interventional study. Eligible patients were 18–80 years old with Spinal Cord Injury or Multiple Sclerosis and Neurogenic Detrusor Overactivity confirmed by a urodynamic study. At baseline, patients underwent urodynamics to confirm neurogenic Detrusor Overactivity. Quality of life was assessed by the Short‐Form (SF) Qualiveen questionnaire. Patients received fesoterodine fumarate 8mg/day for 3 months and were re‐evaluated with Urodynamics and SF Qualiveen. The primary endpoint was the confirmation of the maximum detrusor pressure (Pdetmax) reduction after treatment. Secondary endpoints were: evaluation of maximum bladder capacity and compliance and QoL effect. Statistical analysis included the Wilcoxon test using SPSSv26. Additionally, adverse events, such as dry mouth, constipation and tachycardia, were documented to study the safety of the treatment. One hundred and twenty‐four patients completed the study. Ninety-five of them (76.6%) had Spinal Cord Injury, while 29 (23.4%) had Multiple Sclerosis. Pdetmax, maximum bladder capacity, and compliance had a significant reduction after treatment (p < .001) in the whole group and each subgroup. SF Qualiveen revealed a significant increase in Quality of Life in each group (p < .001). Mild adverse events were reported, related mainly to the worsening of constipation and dry mouth, thus nobody stopped the treatment due to intolerance.Fesoterodine fumarate (8 mg) is a safe and efficacious drug in patients with Spinal Cord Injury and Multiple Sclerosis, as it significantly decreases the detrusor pressure, increases the bladder capacity and compliance, and improves the Quality of Life.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Konstantinidis, Charalampos
- Κωνσταντινίδης, Χαράλαμπος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52038